Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain

Glycobiology

Volumn 26, Issue 1, 2015, Pages 88-99

  Miller, Michelle C ^a   Ippel, Hans ^b   Suylen, Dennis ^b   Klyosov, Anatole A ^c   Traber, Peter G ^c   Hackeng, Tilman ^b   Mayo, Kevin H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Galectin Therapeutics Inc   (United States)

Author keywords

galactose; glycan; lectin; NMR; protein

Indexed keywords

CARBOHYDRATE; GALACTOMANNAN; GALACTOSE; GALECTIN 3; LACTOSE; LECTIN; MANNAN; MANNOSE; POLYSACCHARIDE; PROTEIN BINDING;

ARTICLE; BINDING SITE; DISSOCIATION CONSTANT; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; LIGAND BINDING; MOLECULAR WEIGHT; NOISE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STOICHIOMETRY; TITRIMETRY; AMINO ACID SEQUENCE; CARBOHYDRATE ANALYSIS; CHEMISTRY; GLYCOSYLATION; METABOLISM; MOLECULAR GENETICS; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; BINDING SITES; CARBOHYDRATE SEQUENCE; GALECTIN 3; GLYCOSYLATION; HUMANS; MANNANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84960358625     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwv073     Document Type: Article

References (45)

1. Ahmad N, Gabius H-J, André S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, Brewer CF. 2004. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem. 279:10841-10847.
2. Barondes SH. 2008. Stumbling on galectins. In: Klyosov AA, Witczak ZJ, Platt D, editors, Galectins. Hoboken: Wiley, p. 1-8.
3. Berbís MÁ, André S, Cañada FJ, Pipkorn R, Ippel H, Mayo KH, Kübler D, Gabius HJ, Jiménez-Barbero J. 2014. Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner. Biochem Biophys Res Commun. 443:126-131.
4. Birdsall B, Feeney J, Burdett ID, Bawumia S, Barboni EA, Hughes RC. 2001. NMR solution studies of hamster galectin-3 and electron microscopic visualization of surface-adsorbed complexes: Evidence for interactions between the N-and C-terminal domains. Biochemistry. 40:4859-4866.
5. Daas PJH, Schols HA, de Jongh HHJ. 2000. On the galactosyl distribution of commercial galactomannans. Carbohyd Res. 329:609-619.
6. DawsonH, André S, Karamitopoulou E, Zlobec I, Gabius H-J. 2013. The growing galectin network in colon cancer and clinical relevance of cytoplasmic galectin-3 reactivity. Anticancer Res. 33:3053-3059.
7. Delaglio F, Grzesiek S, VuisterGW, Zhu G, Pfeifer J, Bax A. 1995.NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 6:277-293.
8. Diehl C, Engström O, Delaine T, Hakansson M, Genheden S, Modig K, Leffler H, Ryde U, Nilsson UJ, Akke M. 2010. Protein flexibility and conformational entropy in ligand design targeting the carbohydrate recognition domain of galectin-3. J Am Chem Soc. 132:14577-14589.
9. Ermakova E, Miller MC, Nesmelova IV, Lopez-Merino L, Berbis MA, Nesmelov Y, Tkachev YV, Lagartera L, Daragan VA, André S, et al. 2013. Lactose binding to human galectin-7 ( p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity. Glycobiology. 23:508-523.
10. Gabius H-J, editor. 2009. The Sugar Code. Fundamentals of Glycosciences. Weinheim (Germany): Wiley-VCH.
11. Gabius H-J, André S, Jiménez-Barbero J, Romero A, Solís D. 2011. From lectin structure to functional glycomics: Principles of the sugar code. Trends Biochem Sci. 36:298-313.
12. Gunning AP, Pin C, Morris VJ. 2013. Galectin 3-β-galactobiose interactions. Carbohydr Polym. 92:529-533.
13. Halimi H, Rigato A, Byrne D, Ferracci G, Sebban-Kreuzer C, El Antak L, Guerlesquin F. 2014. Glycan dependence of Galectin-3 self-association properties. PLoS One. 9:e111836.
14. Hernandez JD, Baum LG. 2002. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology. 12:127-136.
15. Ilyina AV, Mestechkina NM, Shcherbukhin VD, Varlamov VP. 2006. Depolymerization of legume seed galactomannan by Celloviridin G20x. Prikladnaya Biokhimiya I Mikrobiologiya. 42:580-586.
16. Ippel H, Miller MC, Berbís MA, Suylen D, André S, Hackeng TM, Cañada FJ, Weber C, Gabius H-J, Jiménez-Barbero J, Mayo KH. 2015. 1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 36 prolinecontaining, full length 29 kDa human chimera-type galectin-3. Biomol NMR Assign. 9:59-63.
17. Johnson BA, Blevins RA. 1994. NMR view: A computer program for the visualization and analysis of NMR data. J Biomol NMR. 4:603-614.
18. Kaltner H, Gabius H-J. 2012. A toolbox of lectins for translating the sugar code: The galectin network in phylogenesis and tumors. Histol Histopathol. 27:397-416.
19. Klyosov AA, Traber PG. 2012. Galectins in disease and potential therapeutic approaches. In: Klyosov AA, Traber PG, editors. Galectins and Disease: Implications for Targeted Therapeutics. Washington, DC: American Chemical Society. p. 3-43.
20. Klyosov AA,Witczak ZJ, PlattD, editors. 2008. Galectins.Hoboken, New Jersey: John Wiley & Sons.
21. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG. 2006. Galectin-3 induces death of Candida species expressing specific β-1,2-linked mannans. J Immunol. 177:4718-4726.
22. Kopitz J, André S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu F-T, Cantz M, et al. 2003. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene. 22:6277-6288.
23. Kopitz J, Bergmann M, Gabius H-J. 2010. How adhesion/growth-regulatory galectins-1 and-3 attain cell specificity: Case study defining their target on neuroblastoma cells (SK-N-MC) and marked affinity regulation by affecting microdomain organization of the membrane. IUBMB Life. 62:624-628.
24. Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M, Gabius H-J. 2001. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem. 276:35917-35923.
25. Krzeminski M, Singh T, André S, Lensch M, Wu AM, Bonvin AM, Gabius HJ. 2011. Human galectin-3 (Mac-2 antigen): Defining molecular switches of affinity to natural glycoproteins, structural and dynamic aspects of glycan binding by flexible ligand docking and putative regulatory sequences in the proximal promoter region. Biochim Biophys Acta. 1810:150-161.
26. Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F. 2004. Introduction to galectins. Glyconj J. 19:433-440.
27. Mestechkina NM, Shcherbukhin VD. 1991. Galactomannan from Galega orientalis Lam. seeds. Appl Biochem Microbiol. 26:648-651.
28. Mey A, Leffler H, Hmama Z, Normier G, Revillard J-P. 1996. The animal lectin Galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol. 156:1572-1577.
29. Miller MC, Klyosov AA, Mayo KH. 2009. The α-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain. Glycobiology. 19:1034-1045.
30. Miller MC, Klyosov AA, Mayo KH. 2012. Structural features for α-galactomannan binding to galectin-1. Glycobiology. 22:543-551.
31. Miller M, Klyosov A, Platt D, Mayo KH. 2009. Using pulse field gradient NMR diffusion measurements to define molecular weight distributions in glycan preparations. Carbohydr Res. 344:1205-1212.
32. Miller MC, Nesmelova IV, Platt D, Klyosov AA, Mayo KH. 2009. Carbohydrate binding domain on galectin-1 is more extensive for a complex glycan than for simple saccharides: Implications for galectin-glycan interactions at the cell surface. Biochem J. 421:211-221.
33. Miller MC, Ribeiro JP, Roldos V, Martín-Santamaría S, Cañada FJ, Nesmelova IA, André S, Pang M, Klyosov AA, Baum LG. 2011. Structural aspects of binding of α-linked digalactosides to human galectin-1. Glycobiology. 21:1627-1641.
34. Morris S, Ahmad N, André S, Kaltner H, Gabius H-J, Brenowitz M, Brewer CF. 2004. Quaternary solution structures of galectins-1,-3, and-7. Glycobiology. 14:293-300.
35. Nesmelova IV, Dings RPM, Mayo KH. 2008. Understanding galectin structurefunction relationships to design effective antagonists. In: Klyosov A. editor. Galectins. New York: Oxford University Press.
36. Nesmelova IV, Ermakova E, Daragan VA, Pang M, Menendez M, Lagartera L, Solis D, Baum LG, Mayo KH. 2010. Lactose binding to galectin-1 modulates structural dynamics, increases conformational entropy, and occurs with apparent negative cooperativity. J Mol Biol. 397:1209-1230.
37. Nesmelova IV, Pang M, Baum LG, Mayo KH. 2008. 1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 29 kDa human galectin-1 protein dimer. Biomol NMR Assign. 2:203-205.
38. Platt D, Klyosov AA, Zomer E. 2006. In: Klyosov AA,Witczak ZJ, Platt D, editors. Carbohydrate Drug Design. American Chem. Soc., ACS Symposium Series 932. Washington, DC: Academic Press. p. 49-66.
39. Plzák J, Betka J, Smetana K Jr, Chovanec M, Kaltner H, André S, Kodet R, Gabius HJ. 2004. Galectin-3-an emerging prognostic indicator in advanced head and neck carcinoma. Eur J Cancer. 40:2324-2330.
40. Sanchez-Ruderisch H, Fischer C, Detjen KM, Welzel M, Wimmel A, Manning JC, André S, Gabius H-J. 2010. Tumor suppressor p16INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J. 277:3552-3563.
41. Seetharaman J, Kanigsberg A, Slaaby R, Leffler H, Barondes SH, Rini JM. 1998. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J Biol Chem. 273:13047-13052.
42. Shcherbukhin VD. 1992. Galactomannans from seeds of the leguminous plants found in the Soviet Union. Food Hydrocolloids. 6:3-7.
43. Smetana K Jr, André S, Kaltner H, Kopitz J, Gabius HJ. 2013. Contextdependent multifunctionality of galectin-1: A challenge for defining the lectin as therapeutic target. Expert Opin Ther Targets. 17:379-392.
44. Werz DB, Ranzinger R, Herget S, Adibekian A, von der Lieth CW, Seeberger PH. 2007. Exploring the structural diversity of mammalian carbohydrates ("glycospace") by statistical databank analysis. ACS Chem Biol. 2:685-691.
45. Woodward AM, Senchyna M, Williams R, Argueso P. 2012. Characterization of the interaction between hydroxypropyl guar galactomannan and galectin-3. Biochem Biophys Res Commun. 424:12-17.